Virtus ETF Advisers LLC Syndax Pharmaceuticals Inc Transaction History

Virtus ETF Advisers LLC

$234 Million
Q4 2024

A detailed history of Virtus ETF Advisers LLC transactions in Syndax Pharmaceuticals Inc stock. As of the latest transaction made, Virtus ETF Advisers LLC holds 5,278 shares of SNDX stock, worth $77,850. This represents 0.03% of its overall portfolio holdings.

Number of Shares

5,278

Previous 4,451 18.58%

Holding current value

$77,850

Previous $85,000 18.82%

% of portfolio

0.03%

Previous 0.04%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	BUY	$12.52 - $21.81 $10,354 - $18,036	827 Added 18.58%	5,278 $69,000
Q3 2024 Nov 14, 2024	BUY	$17.93 - $24.81 $1,398 - $1,935	78 Added 1.78%	4,451 $85,000
Q2 2024 Aug 14, 2024	BUY	$18.82 - $23.79 $263 - $333	14 Added 0.32%	4,373 $89,000
Q1 2024 May 15, 2024	SELL	$19.71 - $24.57 $5,873 - $7,321	-298 Reduced 6.4%	4,359 $103,000
Q4 2023 Feb 15, 2024	BUY	$11.39 - $21.67 $1,423 - $2,708	125 Added 2.76%	4,657 $100,000
Q3 2023 Nov 07, 2023	SELL	$14.52 - $21.77 $6,548 - $9,818	-451 Reduced 9.05%	4,532 $65,000
Q2 2023 Aug 14, 2023	BUY	$19.35 - $22.31 $16,699 - $19,253	863 Added 20.95%	4,983 $104,000
Q1 2023 May 15, 2023	SELL	$20.66 - $28.98 $32,663 - $45,817	-1,581 Reduced 27.73%	4,120 $87,000
Q4 2022 Feb 14, 2023	SELL	$20.64 - $26.24 $19,133 - $24,324	-927 Reduced 13.99%	5,701 $145,000
Q3 2022 Nov 14, 2022	BUY	$18.51 - $24.79 $814 - $1,090	44 Added 0.67%	6,628 $159,000
Q2 2022 Aug 12, 2022	SELL	$13.64 - $19.48 $29,175 - $41,667	-2,139 Reduced 24.52%	6,584 $127,000
Q1 2022 May 16, 2022	SELL	$14.84 - $22.15 $7,642 - $11,407	-515 Reduced 5.57%	8,723 $152,000
Q4 2021 Feb 14, 2022	SELL	$15.23 - $22.47 $30,505 - $45,007	-2,003 Reduced 17.82%	9,238 $202,000
Q3 2021 Nov 15, 2021	SELL	$13.87 - $19.8 $8,238 - $11,761	-594 Reduced 5.02%	11,241 $215,000
Q2 2021 Aug 10, 2021	BUY	$13.42 - $25.18 $93 - $176	7 Added 0.06%	11,835 $203,000
Q1 2021 May 17, 2021	BUY	$19.28 - $24.59 $3,933 - $5,016	204 Added 1.75%	11,828 $264,000
Q4 2020 Feb 12, 2021	SELL	$15.1 - $26.44 $124,877 - $218,658	-8,270 Reduced 41.57%	11,624 $259,000
Q3 2020 Nov 13, 2020	SELL	$13.39 - $17.48 $36,179 - $47,230	-2,702 Reduced 11.96%	19,894 $294,000
Q2 2020 Aug 05, 2020	BUY	$8.94 - $20.98 $202,008 - $474,064	22,596 New	22,596 $335,000

Others Institutions Holding SNDX

# of Institutions

232

Shares Held

96.9M

Call Options Held

1.39M

Put Options Held

543K

View Full List

About Syndax Pharmaceuticals Inc

Ticker SNDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 56,565,200
Market Cap $834M
Description
Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the treatment of MLL-rearranged (MLLr) and nucleophosmin...

More about SNDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

News

Stay updated on Virtus ETF Advisers LLC with notifications on news.

Account

Virtus ETF Advisers LLC Syndax Pharmaceuticals Inc Transaction History